Diplomat Pharmacy Q4 Earnings Preview

Don't be caught off-guard: Diplomat Pharmacy DPLO releases its next round of earnings Monday.

Want to skip the homework and get all the facts in one place? We thought so. Here is your everything-that-matters guide for today's Q4 earnings announcement after the bell.

Earnings and Revenue

Wall Street analysts see Diplomat Pharmacy reporting earnings of 16 cents per share on revenue of $1.17 billion.

In the same quarter last year, Diplomat Pharmacy reported EPS of 8 cents on revenue of $1.14 billion. The analyst consensus estimate would represent a 100 percent increase in the company's earnings. Sales would be have grown 2.18 percent from the same quarter last year.

Here's how the company's reported EPS has compared to analyst estimates in the past:

 

Quarter Q3 2017 Q2 2017 Q1 2017 Q4 2016
EPS Estimate 0.15 0.15 0.15 0.17
EPS Actual 0.25 0.25 0.19 0.08

 

Stock Performance

Over the last 52-week period, shares are up 57.59 percent. Given that these returns are generally positive, long-term shareholders can be content going into this earnings release.

Over the past 90 days, analysts have generally adjusted their estimates higher for EPS and revenues. Analysts seem to have settled on a Neutral rating with Diplomat Pharmacy. The strength of this rating has maintained conviction over the past three months.

Conference Call

Don't be surprised to see the stock move on comments made during its conference call. Diplomat Pharmacy's Q4 conference call is scheduled to begin at 5 p.m. ET and can be accessed here.

Posted In: EarningsNewsPreviewsTrading IdeasEarnings Previews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...